Catalent
CTLT
#1765
Rank
โ‚น1.067 T
Marketcap
โ‚น5,882
Share price
0.00%
Change (1 day)
19.15%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น586.54. In 2023 the company made an earnings per share (EPS) of -โ‚น630.09 a decrease over its 2022 EPS that were of โ‚น210.34.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-16.34%
2023-โ‚น630.09-399.56%
2022โ‚น210.34-30.58%
2021โ‚น303.0079.67%
2020โ‚น168.64114.12%
2019โ‚น78.76-15%
2018โ‚น92.6675.44%
2017โ‚น52.82-22.97%
2016โ‚น68.57-59.56%
2015โ‚น169.57282.05%
2014โ‚น44.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น70.42-87.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น336.36-157.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น69.50-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น137.14-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA